Laxamind 50 Tablet contains Lacosamide 50 mg, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing without affecting normal neuronal excitability. This mechanism helps reduce seizure frequency and severity. Laxamind 50 is typically prescribed as adjunctive therapy in adults and pediatric patients aged 4 years and above. The tablet should be administered orally, with or without food, as directed by a healthcare professional. Dosage adjustments may be required based on clinical response and tolerability, with gradual titration recommended to minimize adverse effects. Common side effects include dizziness, headache, nausea, and fatigue, which are generally mild to moderate in intensity. Caution is advised in patients with cardiac conduction abnormalities, as Lacosamide may prolong PR interval. Regular monitoring of cardiac function and electrolytes is recommended during therapy. Laxamind 50 should be used under strict medical supervision, and patients should be advised not to discontinue therapy abruptly to avoid seizure exacerbation. This medication is contraindicated in individuals with known hypersensitivity to Lacosamide or any of its excipients.